![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Hsd17b8 | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Hsd17b8 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of HSD17B8 mRNA | CTD | PMID:22206623 | Hsd17b8 | Rat | 1,2-dimethylhydrazine | increases expression | ISO | Hsd17b8 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of HSD17B8 mRNA | CTD | PMID:22206623 | Hsd17b8 | Rat | 17beta-estradiol | multiple interactions | ISO | HSD17B8 (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of HSD17B8 mRNA | CTD | PMID:30165855 | Hsd17b8 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HSD17B8 mRNA | CTD | PMID:21215274 | Hsd17b8 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Hsd17b8 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of HSD17B8 mRNA | CTD | PMID:21570461 and PMID:24680724 | Hsd17b8 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HSD17B8 mRNA | CTD | PMID:33387578 | Hsd17b8 | Rat | 2-hydroxypropanoic acid | decreases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of HSD17B8 mRNA | CTD | PMID:30851411 | Hsd17b8 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Hsd17b8 (Mus musculus) | 6480464 | bisphenol S results in increased expression of HSD17B8 mRNA | CTD | PMID:39298647 | Hsd17b8 | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | Hsd17b8 (Mus musculus) | 6480464 | Fenretinide results in increased expression of HSD17B8 mRNA | CTD | PMID:28973697 | Hsd17b8 | Rat | androgen antagonist | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of HSD17B8 mRNA | CTD | PMID:25607892 | Hsd17b8 | Rat | aristolochic acid A | decreases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of HSD17B8 mRNA | CTD | PMID:33212167 | Hsd17b8 | Rat | arsane | multiple interactions | ISO | HSD17B8 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of HSD17B8 mRNA | CTD | PMID:32525701 | Hsd17b8 | Rat | arsenic atom | multiple interactions | ISO | HSD17B8 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of HSD17B8 mRNA | CTD | PMID:32525701 | Hsd17b8 | Rat | arsenous acid | decreases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of HSD17B8 mRNA | CTD | PMID:27829220 | Hsd17b8 | Rat | atrazine | increases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | Atrazine results in increased expression of HSD17B8 mRNA | CTD | PMID:22378314 | Hsd17b8 | Rat | benzo[a]pyrene | decreases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of HSD17B8 mRNA | CTD | PMID:32234424 | Hsd17b8 | Rat | beta-lapachone | increases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | beta-lapachone results in increased expression of HSD17B8 mRNA | CTD | PMID:38218311 | Hsd17b8 | Rat | bis(2-chloroethyl) sulfide | increases expression | ISO | Hsd17b8 (Mus musculus) | 6480464 | Mustard Gas results in increased expression of HSD17B8 mRNA | CTD | PMID:15674844 | Hsd17b8 | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in decreased expression of HSD17B8 mRNA | CTD | PMID:28412506 | Hsd17b8 | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | Hsd17b8 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of HSD17B8 mRNA | CTD | PMID:33754040 | Hsd17b8 | Rat | bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of HSD17B8 mRNA | CTD | PMID:19560483 and PMID:26472102 | Hsd17b8 | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of HSD17B8 mRNA | CTD | PMID:25607892 | Hsd17b8 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of HSD17B8 mRNA | CTD | PMID:25181051 | Hsd17b8 | Rat | Butylbenzyl phthalate | increases expression | EXP | | 6480464 | butylbenzyl phthalate results in increased expression of HSD17B8 mRNA | CTD | PMID:19560483 and PMID:26472102 | Hsd17b8 | Rat | Butylparaben | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of HSD17B8 mRNA | CTD | PMID:25607892 | Hsd17b8 | Rat | cadmium dichloride | decreases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of HSD17B8 mRNA | CTD | PMID:21457566 | Hsd17b8 | Rat | cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of HSD17B8 promoter | CTD | PMID:22457795 | Hsd17b8 | Rat | carbon nanotube | decreases expression | ISO | Hsd17b8 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | Hsd17b8 | Rat | CGP 52608 | multiple interactions | ISO | HSD17B8 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to HSD17B8 gene] | CTD | PMID:28238834 | Hsd17b8 | Rat | chromium(6+) | multiple interactions | ISO | HSD17B8 (Homo sapiens) | 6480464 | [zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of HSD17B8 mRNA | CTD | PMID:38479592 | Hsd17b8 | Rat | cisplatin | affects response to substance | ISO | HSD17B8 (Homo sapiens) | 6480464 | HSD17B8 protein affects the susceptibility to Cisplatin | CTD | PMID:16217747 | Hsd17b8 | Rat | cisplatin | increases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of HSD17B8 mRNA | CTD | PMID:27392435 | Hsd17b8 | Rat | cisplatin | multiple interactions | ISO | HSD17B8 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of HSD17B8 mRNA | CTD | PMID:27392435 | Hsd17b8 | Rat | cobalt dichloride | decreases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of HSD17B8 mRNA | CTD | PMID:19376846 | Hsd17b8 | Rat | copper(II) sulfate | decreases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of HSD17B8 mRNA | CTD | PMID:19549813 | Hsd17b8 | Rat | coumestrol | increases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | Coumestrol results in increased expression of HSD17B8 mRNA | CTD | PMID:19167446 | Hsd17b8 | Rat | cyclosporin A | increases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of HSD17B8 mRNA | CTD | PMID:27989131 | Hsd17b8 | Rat | DDE | increases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of HSD17B8 mRNA | CTD | PMID:38568856 | Hsd17b8 | Rat | deguelin | decreases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | deguelin results in decreased expression of HSD17B8 mRNA | CTD | PMID:33512557 | Hsd17b8 | Rat | diarsenic trioxide | decreases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of HSD17B8 mRNA | CTD | PMID:27829220 | Hsd17b8 | Rat | Dibutyl phosphate | affects expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of HSD17B8 mRNA | CTD | PMID:37042841 | Hsd17b8 | Rat | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of HSD17B8 mRNA | CTD | PMID:19560483 and PMID:26472102 | Hsd17b8 | Rat | diethyl phthalate | increases expression | EXP | | 6480464 | diethyl phthalate results in increased expression of HSD17B8 mRNA | CTD | PMID:26472102 | Hsd17b8 | Rat | diethylstilbestrol | decreases expression | EXP | | 6480464 | Diethylstilbestrol results in decreased expression of HSD17B8 mRNA | CTD | PMID:36653537 | Hsd17b8 | Rat | dipentyl phthalate | increases expression | EXP | | 6480464 | di-n-pentyl phthalate results in increased expression of HSD17B8 mRNA | CTD | PMID:19560483 and PMID:26472102 | Hsd17b8 | Rat | dorsomorphin | multiple interactions | ISO | HSD17B8 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Hsd17b8 | Rat | elemental selenium | increases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | Selenium results in increased expression of HSD17B8 mRNA | CTD | PMID:19244175 | Hsd17b8 | Rat | entinostat | increases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | entinostat results in increased expression of HSD17B8 mRNA | CTD | PMID:27188386 | Hsd17b8 | Rat | enzacamene | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of HSD17B8 mRNA | CTD | PMID:25607892 | Hsd17b8 | Rat | folic acid | multiple interactions | ISO | Hsd17b8 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of HSD17B8 mRNA | CTD | PMID:22206623 | Hsd17b8 | Rat | genistein | increases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | Genistein results in increased expression of HSD17B8 protein | CTD | PMID:20884965 | Hsd17b8 | Rat | genistein | multiple interactions | ISO | HSD17B8 (Homo sapiens) | 6480464 | ESR2 promotes the reaction [Genistein results in increased expression of HSD17B8 protein] | CTD | PMID:20884965 | Hsd17b8 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of HSD17B8 mRNA | CTD | PMID:33387578 | Hsd17b8 | Rat | gossypol | multiple interactions | ISO | HSD17B8 (Homo sapiens) | 6480464 | [Gossypol co-treated with NAD] binds to HSD17B8 protein | CTD | PMID:25526675 | Hsd17b8 | Rat | isobutanol | multiple interactions | ISO | HSD17B8 (Homo sapiens) | 6480464 | [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of HSD17B8 mRNA | CTD | PMID:29432896 | Hsd17b8 | Rat | ivermectin | decreases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of HSD17B8 protein | CTD | PMID:32959892 | Hsd17b8 | Rat | lead(0) | affects methylation | ISO | HSD17B8 (Homo sapiens) | 6480464 | Lead affects the methylation of HSD17B8 gene | CTD | PMID:31636367 | Hsd17b8 | Rat | mercury dibromide | decreases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | mercuric bromide results in decreased expression of HSD17B8 mRNA | CTD | PMID:26272509 | Hsd17b8 | Rat | mercury dibromide | multiple interactions | ISO | HSD17B8 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HSD17B8 mRNA | CTD | PMID:27188386 | Hsd17b8 | Rat | methylmercury chloride | decreases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of HSD17B8 mRNA | CTD | PMID:28001369 | Hsd17b8 | Rat | mifepristone | decreases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | Mifepristone results in decreased expression of HSD17B8 mRNA | CTD | PMID:17584828 | Hsd17b8 | Rat | N-acetyl-L-cysteine | multiple interactions | ISO | HSD17B8 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [SOD2 protein affects the expression of HSD17B8 mRNA] | CTD | PMID:18829485 | Hsd17b8 | Rat | N-methyl-4-phenylpyridinium | increases expression | ISO | Hsd17b8 (Mus musculus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of HSD17B8 mRNA | CTD | PMID:22776087 | Hsd17b8 | Rat | NAD zwitterion | multiple interactions | ISO | HSD17B8 (Homo sapiens) | 6480464 | [Gossypol co-treated with NAD] binds to HSD17B8 protein | CTD | PMID:25526675 | Hsd17b8 | Rat | NAD(+) | multiple interactions | ISO | HSD17B8 (Homo sapiens) | 6480464 | [Gossypol co-treated with NAD] binds to HSD17B8 protein | CTD | PMID:25526675 | Hsd17b8 | Rat | NADP zwitterion | multiple interactions | ISO | HSD17B8 (Homo sapiens) | 6480464 | NADP binds to and results in increased activity of HSD17B8 protein | CTD | PMID:25526675 | Hsd17b8 | Rat | NADP(+) | multiple interactions | ISO | HSD17B8 (Homo sapiens) | 6480464 | NADP binds to and results in increased activity of HSD17B8 protein | CTD | PMID:25526675 | Hsd17b8 | Rat | ozone | multiple interactions | ISO | Hsd17b8 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of HSD17B8 mRNA | CTD | PMID:34911549 | Hsd17b8 | Rat | p-chloromercuribenzoic acid | decreases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in decreased expression of HSD17B8 mRNA | CTD | PMID:26272509 | Hsd17b8 | Rat | p-chloromercuribenzoic acid | multiple interactions | ISO | HSD17B8 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HSD17B8 mRNA | CTD | PMID:27188386 | Hsd17b8 | Rat | paracetamol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of HSD17B8 mRNA | CTD | PMID:25607892 | Hsd17b8 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of HSD17B8 mRNA | CTD | PMID:33387578 | Hsd17b8 | Rat | paracetamol | decreases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of HSD17B8 mRNA | CTD | PMID:29067470 | Hsd17b8 | Rat | phenylmercury acetate | decreases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of HSD17B8 mRNA | CTD | PMID:26272509 | Hsd17b8 | Rat | phenylmercury acetate | multiple interactions | ISO | HSD17B8 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HSD17B8 mRNA | CTD | PMID:27188386 | Hsd17b8 | Rat | pirinixic acid | increases expression | ISO | Hsd17b8 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of HSD17B8 mRNA | CTD | PMID:17426115 | Hsd17b8 | Rat | rac-lactic acid | decreases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of HSD17B8 mRNA | CTD | PMID:30851411 | Hsd17b8 | Rat | SB 431542 | multiple interactions | ISO | HSD17B8 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Hsd17b8 | Rat | selenium atom | increases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | Selenium results in increased expression of HSD17B8 mRNA | CTD | PMID:19244175 | Hsd17b8 | Rat | sodium arsenate | multiple interactions | ISO | HSD17B8 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of HSD17B8 mRNA | CTD | PMID:32525701 | Hsd17b8 | Rat | sodium arsenite | decreases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of HSD17B8 mRNA | CTD | PMID:38568856 | Hsd17b8 | Rat | sunitinib | decreases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of HSD17B8 mRNA | CTD | PMID:31533062 | Hsd17b8 | Rat | tetrachloroethene | decreases expression | ISO | Hsd17b8 (Mus musculus) | 6480464 | Tetrachloroethylene results in decreased expression of HSD17B8 mRNA | CTD | PMID:28973375 | Hsd17b8 | Rat | tetrachloromethane | decreases expression | ISO | Hsd17b8 (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of HSD17B8 mRNA | CTD | PMID:31919559 | Hsd17b8 | Rat | thifluzamide | decreases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | thifluzamide results in decreased expression of HSD17B8 mRNA | CTD | PMID:33512557 | Hsd17b8 | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of HSD17B8 mRNA | CTD | PMID:34492290 | Hsd17b8 | Rat | thiram | decreases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | Thiram results in decreased expression of HSD17B8 mRNA | CTD | PMID:38568856 | Hsd17b8 | Rat | tris(2-butoxyethyl) phosphate | increases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | tris(2-butoxyethyl) phosphate results in increased expression of HSD17B8 mRNA | CTD | PMID:29024780 | Hsd17b8 | Rat | tunicamycin | increases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | Tunicamycin results in increased expression of HSD17B8 mRNA | CTD | PMID:29453283 | Hsd17b8 | Rat | urethane | decreases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | Urethane results in decreased expression of HSD17B8 mRNA | CTD | PMID:28818685 | Hsd17b8 | Rat | valproic acid | affects expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of HSD17B8 mRNA | CTD | PMID:25979313 | Hsd17b8 | Rat | valproic acid | increases expression | ISO | Hsd17b8 (Mus musculus) | 6480464 | Valproic Acid results in increased expression of HSD17B8 mRNA | CTD | PMID:21427059 | Hsd17b8 | Rat | valproic acid | increases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of HSD17B8 mRNA | CTD | PMID:19101580 more ... | Hsd17b8 | Rat | vitamin E | increases expression | ISO | HSD17B8 (Homo sapiens) | 6480464 | Vitamin E results in increased expression of HSD17B8 mRNA | CTD | PMID:19244175 | Hsd17b8 | Rat | XL147 | multiple interactions | ISO | Hsd17b8 (Mus musculus) | 6480464 | XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of HSD17B8 mRNA] | CTD | PMID:29891994 | |